Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Which Credit Card Rewards Program Is Best
Uncover which credit card rewards program is best for your lifestyle. Compare various options to maximize your rewards potential.
23,688 articles
Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Wall Street About Fund SpaceX IPO for Mars City Plans
SpaceX has filed its S-1 to go public, presenting a three-pronged business plan that could fund a city on Mars. Here ...
Social Security’s Special Minimum Shrinks Further in 2026
In 2026, social security’s special minimum is fading for new retirees. Fewer than 30,000 people still qualify, with m...
Reasons Wait Before Buying: 2 Holds, 1 Buy SpaceX Today
Investing in a high-flying name like SpaceX can spark excitement. This article breaks down two strong reasons to wait...
Major Binance Announcement Concerning Philippines Rollout Spurs Crypto Markets
Binance unveiled a sweeping move into the Philippines under a regulatory sandbox, a move critics say banks on Asia gr...
The $5.25 Billion Paying Dividends ETF Surges in 2026
In mid-2026, the Amplify CWP Enhanced Dividend Income ETF climbs past $5.25 billion in assets as its monthly distribu...
Lockheed Stock 2026 Rally Real: Earnings Drive Surge
Lockheed Martin has surged in 2026, led by a robust backlog and growing cash flow that underpin a genuine stock 2026 ...
Thinking Switching Medicare Advantage? Read This First
Retirees often weigh Medicare Advantage against Original Medicare. Here’s a practical, numbers-backed guide to decide...
Amazon Drops What Macro? Pressure Weighs on AMZN Stock
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Prediction: Poet Stock’s Outlook Darkens After Results
POET Technologies posted a quarterly miss as a Lumilens deal slows and litigation casts a shadow over growth prospect...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status